{"transactions":[{"id":722096,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER SVP AND CFO"}}],"security":"Common Stock (Option)","published_at":"2026-07-01T20:49:07.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Inc. whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on the first anniversary of the grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0.8479,"expiration_date":"2032-06-26","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000912282-26-000895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000895/form4.xml","form_type":"4"}},{"id":722095,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER SVP AND CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-01T20:49:07.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Inc. whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on the first anniversary of the grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0.66,"expiration_date":"2033-01-19","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000912282-26-000895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000895/form4.xml","form_type":"4"}},{"id":722094,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER SVP AND CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-01T20:49:07.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Inc. whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on the first anniversary of the grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2034-02-05","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000912282-26-000895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000895/form4.xml","form_type":"4"}},{"id":722093,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER SVP AND CFO"}}],"security":"Common Shares","published_at":"2026-07-01T20:49:07.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22,"price":1.72,"value":37.84,"ownership":{"direct":false,"nature":"Fletcher Payne 2019 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Inc. whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a price of C$2.41 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from Canadian price of C$2.41 per share using an exchange rate of C$1.4 = US$1.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000912282-26-000895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000895/form4.xml","form_type":"4"}},{"id":722092,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER SVP AND CFO"}}],"security":"Common Shares","published_at":"2026-07-01T20:49:07.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":222,"price":1.72,"value":381.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Inc. whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a price of C$2.41 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from Canadian price of C$2.41 per share using an exchange rate of C$1.4 = US$1.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000912282-26-000895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000895/form4.xml","form_type":"4"}},{"id":1655913,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"officer":true,"officer_title":"Sr VP and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-07T23:06:38.000Z","date":"2024-02-05","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the options vest on February 5, 2025, and the remaining options vesting as follows:  1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028."}],"balance_after":55000,"derivative":{"exercise_price":2,"expiration_date":"2034-02-05","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000912282-24-000134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228224000134/form4.xml","form_type":"4"}},{"id":2049020,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP & Chief Fin. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-24T00:57:29.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on January 19, 2024; the remaining fifty percent (50%) vest as follows:  One-third (1/3) on January 19, 2025; one-third (1/3) on January 19, 2026; and one-third (1/3) on January 19, 2027."}],"balance_after":200000,"derivative":{"exercise_price":0.66,"expiration_date":"2033-01-19","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-23-001162","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761923001162/doc1.xml","form_type":"4"}},{"id":2049019,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP & Chief Fin. Officer"}}],"security":"Common Shares","published_at":"2023-01-24T00:57:29.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001567619-23-001162","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761923001162/doc1.xml","form_type":"4"}},{"id":2153750,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP & Chief Fin. Officer"}}],"security":"Common Shares","published_at":"2022-09-21T22:06:09.000Z","date":"2022-09-19","kind":"purchase","acquired":true,"shares":10000,"price":0.6775,"value":6775.0,"ownership":{"direct":false,"nature":"Fletcher Payne 2019 Trust"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-22-017697","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761922017697/doc1.xml","form_type":"4"}},{"id":2220547,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP & Chief Fin. Officer"}}],"security":"Common Stock","published_at":"2022-06-28T20:16:43.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  50% of the options vest on 6/27/2023; the remaining options will vest in equal annual installments on June 27, 2024, June 27, 2025, and June 27, 2026."}],"balance_after":1000000,"derivative":{"exercise_price":0.8479,"expiration_date":"2032-06-26","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001567619-22-013453","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761922013453/doc1.xml","form_type":"4"}},{"id":3441361,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-12T20:22:52.000Z","date":"2019-08-12","kind":"grant","acquired":true,"shares":1180,"price":6.51,"value":7681.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan (\"ESPP\") on August 12, 2019."}],"balance_after":3744,"source":{"system":"sec-edgar","filing":"0001209191-19-045506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119045506/doc4.xml","form_type":"4"}},{"id":3660810,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-14T00:19:37.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":1002,"price":7.04,"value":7054.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan (\"ESPP\") on February 11, 2019."}],"balance_after":3731,"source":{"system":"sec-edgar","filing":"0001209191-19-009885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119009885/doc4.xml","form_type":"4"}},{"id":3677851,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T21:52:30.000Z","date":"2019-02-04","kind":"exercise","acquired":false,"shares":1503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":73497,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":1503},"source":{"system":"sec-edgar","filing":"0001209191-19-006858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119006858/doc4.xml","form_type":"4"}},{"id":3677850,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-04T21:52:30.000Z","date":"2019-02-04","kind":"exercise","acquired":true,"shares":1503,"price":4.63,"value":6958.89,"ownership":{"direct":true},"balance_after":3230,"source":{"system":"sec-edgar","filing":"0001209191-19-006858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119006858/doc4.xml","form_type":"4"}},{"id":3685541,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-28T23:56:23.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019."}],"balance_after":38000,"derivative":{"exercise_price":7.97,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001209191-19-005667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119005667/doc4.xml","form_type":"4"}},{"id":3857006,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T21:48:03.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests monthly over four (4) years starting June 13, 2018."}],"balance_after":25000,"derivative":{"exercise_price":9.68,"expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-044790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118044790/doc4.xml","form_type":"4"}},{"id":3981035,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-28T20:11:07.000Z","date":"2018-03-26","kind":"exercise","acquired":false,"shares":59,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":74941,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":59},"source":{"system":"sec-edgar","filing":"0001209191-18-021896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118021896/doc4.xml","form_type":"4"}},{"id":3981034,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-28T20:11:07.000Z","date":"2018-03-26","kind":"exercise","acquired":true,"shares":59,"price":4.63,"value":273.17,"ownership":{"direct":true},"balance_after":59,"source":{"system":"sec-edgar","filing":"0001209191-18-021896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118021896/doc4.xml","form_type":"4"}},{"id":4099504,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-16T20:43:03.000Z","date":"2018-01-12","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing January 12, 2018."}],"balance_after":26000,"derivative":{"exercise_price":15.13,"expiration_date":"2028-01-12","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000899243-18-001063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000089924318001063/doc4.xml","form_type":"4"}},{"id":4258459,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34261,"kind":"person","name":"Payne Fletcher","position":1,"cik":"0001650476","reported_name":"Payne Fletcher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-12T20:47:23.000Z","date":"2017-07-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":75000,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-044901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117044901/doc4.xml","form_type":"4"}}]}